Współczesna Onkologia

Abstract

1/2012 vol. 16
Review paper

Chemotherapy-induced polyneuropathy. Part I. Pathophysiology [Polish version: Polineuropatia wywołana chemioterapią. Część I. Patofizjologia p. 79]

Wspolczesna Onkol 2012; 16 (1): 72–78
[Polish version: Wspolczesna Onkol 2012; 16 (1): 79–85]
Online publish date: 2012/02/29
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Chemotherapy-induced peripheral neuropathy (CIPN) is a toxic neuropathy, a syndrome consisting of highly distressing symptoms of various degrees of severity. It includes numbness of distal extremities, long-term touch, heat, and cold dysaesthesia and, in more severe cases, motor impairment affecting daily functioning. Each form of the syndrome may be accompanied by symptoms of neuropathic stinging, burning, and tingling pain. In the case of most chemotherapeutic agents, the incidence and severity of CIPN are dependent on the cumulative dose of the drug. The syndrome described is caused by damage to the axons and/or cells of the peripheral nervous system.

Chemotherapeutic agents have distinct mechanisms of action in both neoplastic tissue and the peripheral nervous system; therefore, CIPN should not be regarded as a homogeneous disease entity. The present article is an attempt to systematize the knowledge about the toxic effects of chemotherapy on the peripheral nervous system.
Share
without publication fees